Literature DB >> 31783180

Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.

Raymond U Osarogiagbon1, Nicholas R Faris2, Walter Stevens2, Carrie Fehnel2, Cheryl Houston-Harris2, Philip Ojeabulu2, Olawale A Akinbobola2, Yu-Shen Lee3, Meredith A Ray3, Matthew P Smeltzer3.   

Abstract

INTRODUCTION: The International Association for the Study of Lung Cancer's (IASLC's) proposal to recategorize the residual tumor (R) classification for resected NSCLC needs validation.
METHODS: Using a 2009 to 2019 population-based multi-institutional NSCLC resection cohort from the United States, we classified resections by Union for International Cancer Control (UICC) and IASLC R criteria and compared the distribution of R classification variables and their survival associations.
RESULTS: Of 3361 resections, 95.3% were R0, 4.3% were R1, and 0.4% were R2 by UICC criteria; 33.3% were R0, 60.8% were R-uncertain, and 5.8% were R1/2 by IASLC criteria; 2044 patients (63.8%) migrated from UICC R0 to IASLC R-uncertain. Median survival was not reached, 69 (95% confidence interval [CI]: 64-77), and 25 (95% CI: 18-36) months, respectively, for patients with IASLC R0, R-uncertain, and R1 or R2 resections. Failure to achieve nodal dissection criteria caused 98% of migration to R-uncertainty, metastasis to the highest mediastinal node station, 5.8%. Compared with R0, R-uncertain resections with mediastinal nodes, no mediastinal nodes, and no nodes had adjusted hazard ratios of 1.28 (95% CI: 1.10-1.48), 1.47 (95% CI: 1.24-1.74), and 1.74 (95% CI: 1.37-2.21), respectively, suggesting a dose-response relationship between nodal R-uncertainty and survival. Accounting for mediastinal nodal involvement, the highest mediastinal station involvement was not independently prognostic. The incomplete resection variables were uniformly prognostic.
CONCLUSIONS: The proposed R classification recategorization variables were mostly prognostic, except the highest mediastinal nodal station involvement. Further categorization of R-uncertainty by severity of nodal quality deficit should be considered.
Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complete; Incomplete; Lung cancer; Lymph node; Resection margin; Staging

Year:  2019        PMID: 31783180      PMCID: PMC7044063          DOI: 10.1016/j.jtho.2019.11.009

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  26 in total

1.  Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Ann Thorac Surg       Date:  2018-05-28       Impact factor: 4.330

2.  Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases.

Authors:  Romano Demicheli; Marco Fornili; Federico Ambrogi; Kristin Higgins; Jessamy A Boyd; Elia Biganzoli; Chris R Kelsey
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

3.  Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.

Authors:  Matteo Gagliasso; Giuseppe Migliaretti; Francesco Ardissone
Journal:  Lung Cancer       Date:  2017-07-20       Impact factor: 5.705

Review 4.  Complete resection in lung cancer surgery: proposed definition.

Authors:  Ramón Rami-Porta; Christian Wittekind; Peter Goldstraw
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

5.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

Review 6.  Residual disease at the bronchial stump after curative resection for lung cancer.

Authors:  Jan Wind; Egbert J Smit; Suresh Senan; Jan-Peter Eerenberg
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-27       Impact factor: 4.191

7.  Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma.

Authors:  Whitney S Brandt; Ilies Bouabdallah; Kay See Tan; Bernard J Park; Prasad S Adusumilli; Daniela Molena; Manjit S Bains; James Huang; James M Isbell; Matthew J Bott; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-13       Impact factor: 5.209

8.  Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.

Authors:  Raymond U Osarogiagbon; Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

9.  Survival Before and After Direct Surgical Quality Feedback in a Population-Based Lung Cancer Cohort.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Carrie Fehnel; Cheryl Houston-Harris; Philip Ojeabulu; Olawale Akinbobola; Yu-Sheng Lee; Meghan Meadows; R Samuel Signore; Lynn Wiggins; David Talton; Edmond Owen; Lawrence E Deese; Richard Eubanks; Bradley A Wolf; Paul Levy; E Todd Robbins; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2018-12-27       Impact factor: 4.330

10.  Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Jeffrey W Allen; Aamer Farooq; Allen Berry; David Spencer; Thomas O'Brien
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

View more
  7 in total

1.  Sleeve lobectomy and pneumonectomy: can they really be properly compared?

Authors:  Ramón Rami-Porta; Sergi Call
Journal:  Transl Lung Cancer Res       Date:  2020-06

2.  Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.

Authors:  Raymond U Osarogiagbon; Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Carrie Fehnel; Phillip Ojeabulu; Olawale Akinbobola; Meghan Meadows-Taylor; Laura M McHugh; Ahmed M Halal; Paul Levy; Vishal Sachdev; David Talton; Lynn Wiggins; Xiao-Ou Shu; Yu Shyr; Edward T Robbins; Lisa M Klesges
Journal:  J Thorac Oncol       Date:  2021-02-16       Impact factor: 15.609

3.  Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.

Authors:  Meredith A Ray; Carrie Fehnel; Olawale Akinbobola; Nicholas R Faris; Meghan Taylor; Alicia Pacheco; Matthew P Smeltzer; Raymond U Osarogiagbon
Journal:  J Thorac Oncol       Date:  2021-02-12       Impact factor: 15.609

4.  Volume-Based Care Regionalization: Pitfalls and Challenges.

Authors:  Raymond U Osarogiagbon
Journal:  J Clin Oncol       Date:  2020-09-08       Impact factor: 50.717

5.  New TNM staging in lung cancer (8th edition) and future perspectives.

Authors:  José-María Matilla; M Zabaleta; E Martínez-Téllez; J Abal; A Rodríguez-Fuster; J Hernández-Hernández
Journal:  J Clin Transl Res       Date:  2020-09-02

6.  Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Carrie Fehnel; Olawale Akinbobola; Andrea Saulsberry; Meghan Meadows-Taylor; Alicia Pacheco; Meredith Ray; Raymond U Osarogiagbon
Journal:  JTO Clin Res Rep       Date:  2021-03-09

7.  The Evolving Concept of Complete Resection in Lung Cancer Surgery.

Authors:  Ramón Rami-Porta
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.